Cosmos Health Inc. (COSM) 10-Year Financial Performance & Capital Metrics

COSM • • Industrial / General

HealthcareSpecialty & Generic PharmaConsumer HealthcareOTC Medications

AboutCosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.Show more

Revenue $54M +2.0%
EBITDA -$14M +32.6%
Net Income -$16M +12.7%
EPS (Diluted) -1.17 +45.6%
Gross Margin 7.92% -2.8%
EBITDA Margin -26.27% +33.9%
Operating Margin -28.56% +30.2%
Net Margin -29.73% +14.4%
ROE -53.43% -9.1%
ROIC -28.9% +33.3%
Debt/Equity 0.48 +39.8%
Interest Coverage -15.36 +39.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading at only 0.4x book value
✓Efficient asset utilization: 1.0x turnover

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Shares diluted 60.0% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y21.7%

5Y6.53%

3Y-1.09%

TTM6.69%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM9.07%

EPS CAGR

10Y-

5Y-

3Y-

TTM49.2%

ROCE

10Y Avg-19.93%

5Y Avg-8.65%

3Y Avg-38.87%

Latest-44.26%

Peer Comparison

OTC Medications

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HLNHaleon plc	43.51B	9.77	30.53	-0.61%	11.72%	16.31%	4.71%	0.62
UPCUniverse Pharmaceuticals Inc.	2.59M	4.59	-0.00	-28.74%	-37.94%	-31.64%		0.18
PRPHProPhase Labs, Inc.	711.94K	0.17	-0.07	-84.75%	-38.72%	-6.08%		3.34
COSMCosmos Health Inc.	20.24M	0.54	-0.46	1.97%	-31.01%	-80.15%		0.48
PRGOPerrigo Company plc	2.09B	15.17	-12.14	-6.06%	-1.21%	-1.17%	11.72%	0.84

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	533.8K	6.76M	30.01M	37.08M	39.68M	55.41M	56.24M	50.35M	53.38M	54.43M
Revenue Growth %	-0.93%	11.66%	3.44%	0.24%	0.07%	0.4%	0.02%	-0.1%	0.06%	0.02%
Cost of Goods Sold+	484.81K	6.15M	28.06M	34.68M	36.01M	47.35M	47.91M	44.39M	49.03M	50.12M
COGS % of Revenue	0.91%	0.91%	0.93%	0.94%	0.91%	0.85%	0.85%	0.88%	0.92%	0.92%
Gross Profit+	48.99K	601.04K	1.96M	2.41M	3.66M	8.06M	8.33M	5.96M	4.35M	4.31M
Gross Margin %	0.09%	0.09%	0.07%	0.06%	0.09%	0.15%	0.15%	0.12%	0.08%	0.08%
Gross Profit Growth %	-0.99%	11.27%	2.25%	0.23%	0.52%	1.2%	0.03%	-0.28%	-0.27%	-0.01%
Operating Expenses+	491.45K	803.55K	6.83M	3.64M	3.92M	5.35M	12.86M	13.43M	26.18M	19.86M
OpEx % of Revenue	0.92%	0.12%	0.23%	0.1%	0.1%	0.1%	0.23%	0.27%	0.49%	0.36%
Selling, General & Admin	486.04K	794.1K	4.85M	3.59M	3.52M	4.95M	12.41M	13.24M	25.57M	12.09M
SG&A % of Revenue	0.91%	0.12%	0.16%	0.1%	0.09%	0.09%	0.22%	0.26%	0.48%	0.22%
Research & Development	0	0	0	0	0	0	0	0	0	533.29K
R&D % of Revenue	-	-	-	-	-	-	-	-	-	0.01%
Other Operating Expenses	5.42K	9.45K	1.98M	43.93K	394.63K	397.6K	449.69K	188.89K	614.38K	7.23M
Operating Income+	-442.46K	-202.51K	-4.87M	-1.23M	-255.81K	2.71M	-4.53M	-7.47M	-21.83M	-15.54M
Operating Margin %	-0.83%	-0.03%	-0.16%	-0.03%	-0.01%	0.05%	-0.08%	-0.15%	-0.41%	-0.29%
Operating Income Growth %	-1.06%	0.54%	-23.06%	0.75%	0.79%	11.61%	-2.67%	-0.65%	-1.92%	0.29%
EBITDA+	-437.04K	-193.06K	-4.85M	-1.18M	138.82K	3.11M	-4.08M	-7.29M	-21.22M	-14.3M
EBITDA Margin %	-0.82%	-0.03%	-0.16%	-0.03%	0%	0.06%	-0.07%	-0.14%	-0.4%	-0.26%
EBITDA Growth %	-1.06%	0.56%	-24.1%	0.76%	1.12%	21.42%	-2.31%	-0.78%	-1.91%	0.33%
D&A (Non-Cash Add-back)	5.42K	9.45K	25.9K	43.93K	394.63K	397.6K	449.69K	188.89K	614.38K	1.25M
EBIT	-6.6M	-394.22K	-4.57M	-2.24M	-1.38M	3.99M	-4.27M	-9.09M	-17.68M	-15.17M
Net Interest Income+	-89.32K	-206.01K	-1.64M	-6.81M	-1.73M	-2.73M	-3.53M	-3.73M	-203.62K	-605.87K
Interest Income	1.06K	0	0	0	0	65.86K	46.32K	236.35K	662.86K	406.45K
Interest Expense	90.38K	206.01K	1.64M	6.81M	1.73M	2.8M	3.58M	3.97M	866.48K	1.01M
Other Income/Expense	-6.25M	-397.73K	-1.33M	-7.81M	-2.86M	-1.52M	-3.31M	-5.58M	3.29M	-638.19K
Pretax Income+	-6.69M	-600.23K	-6.21M	-9.04M	-3.12M	1.2M	-7.85M	-13.06M	-18.54M	-16.18M
Pretax Margin %	-12.53%	-0.09%	-0.21%	-0.24%	-0.08%	0.02%	-0.14%	-0.26%	-0.35%	-0.3%
Income Tax+	203	769	2.8K	17.33K	182.81K	377.54K	114.01K	775.05K	0	0
Effective Tax Rate %	1%	1%	1%	1%	1.06%	0.68%	1.01%	1.06%	1%	1%
Net Income+	-6.69M	-601K	-6.21M	-9.06M	-3.3M	820.79K	-7.96M	-13.83M	-18.54M	-16.18M
Net Margin %	-12.53%	-0.09%	-0.21%	-0.24%	-0.08%	0.01%	-0.14%	-0.27%	-0.35%	-0.3%
Net Income Growth %	-2.11%	0.91%	-9.33%	-0.46%	0.64%	1.25%	-10.7%	-0.74%	-0.34%	0.13%
Net Income (Continuing)	-6.69M	-601K	-6.21M	-9.06M	-3.3M	820.79K	-7.96M	-13.83M	-18.54M	-16.18M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-13.31	-1.20	-12.25	-17.02	-6.21	1.54	-23.74	-33.16	-2.15	-1.17
EPS Growth %	-2.06%	0.91%	-9.21%	-0.39%	0.64%	1.25%	-16.42%	-0.4%	0.94%	0.46%
EPS (Basic)	-13.31	-1.25	-12.25	-17.02	-6.21	1.55	-23.74	-33.16	-2.15	-1.17
Diluted Shares Outstanding	502.46K	502.59K	511.2K	532.26K	530.94K	532.31K	656.93K	1.93M	11.97M	19.15M
Basic Shares Outstanding	502.46K	480.8K	506.92K	532.26K	530.94K	530.8K	656.93K	1.93M	11.97M	19.15M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	547.18K	2.64M	9.51M	18.35M	21.18M	40.77M	39.83M	56.04M	36.61M	25.46M
Cash & Short-Term Investments	198.05K	716.59K	782.85K	3.58M	277.48K	851.19K	297.95K	20.76M	3.85M	336.25K
Cash Only	198.05K	716.59K	782.85K	864.34K	38.54K	628.39K	286.49K	20.75M	3.83M	315.11K
Short-Term Investments	0	0	0	2.72M	238.94K	222.79K	11.47K	14.88K	20.07K	21.15K
Accounts Receivable	96.54K	793.75K	1.43M	4.94M	9.27M	26.91M	30.14M	22.76M	21.71M	15.88M
Days Sales Outstanding	66.01	42.89	17.35	48.65	85.26	177.27	195.59	165.02	148.47	106.5
Inventory	191.87K	464.22K	3.09M	3.2M	3.47M	3.29M	3.15M	3.45M	4.79M	4.36M
Days Inventory Outstanding	144.46	27.53	40.24	33.71	35.21	25.38	23.98	28.38	35.65	31.72
Other Current Assets	0	0	772.62K	189.76K	665.49K	1.1M	-4.77K	9.07M	1.95M	4.89M
Total Non-Current Assets+	110.44K	481.92K	1.17M	2.35M	2.7M	3.07M	9.6M	11.67M	29.41M	28.85M
Property, Plant & Equipment	50.53K	52.72K	114.57K	1.43M	1.73M	1.76M	2.93M	2.93M	11.62M	10.4M
Fixed Asset Turnover	10.56x	128.15x	261.97x	26.01x	22.87x	31.53x	19.17x	17.18x	4.60x	5.23x
Goodwill	0	0	0	49.7K	49.7K	49.7K	49.7K	49.7K	49.7K	49.7K
Intangible Assets	0	0	41.99K	247.07K	213.98K	180.81K	436.07K	657.22K	7.63M	7.71M
Long-Term Investments	0	0	0	0	4.38K	0	0	0	165.93K	5.77M
Other Non-Current Assets	59.92K	429.2K	1.01M	624.48K	698.06K	905.32K	5.33M	8.03M	9.94M	4.92M
Total Assets+	657.62K	3.12M	10.68M	20.69M	23.88M	43.84M	49.43M	68.04M	66.01M	54.31M
Asset Turnover	0.81x	2.17x	2.81x	1.79x	1.66x	1.26x	1.14x	0.74x	0.81x	1.00x
Asset Growth %	-0.91%	3.74%	2.42%	0.94%	0.15%	0.84%	0.13%	0.38%	-0.03%	-0.18%
Total Current Liabilities+	1.91M	4.87M	13.7M	22.27M	28.24M	34.29M	29.93M	21.75M	24.32M	25.76M
Accounts Payable	336.93K	591.69K	2.17M	5.93M	8M	11.97M	12.13M	10.26M	11.91M	11.16M
Days Payables Outstanding	253.67	35.09	28.18	62.46	81.1	92.31	92.39	84.36	88.68	81.26
Short-Term Debt	474.14K	3.2M	10.18M	15.02M	18.65M	19.7M	13.34M	8.04M	8.23M	9.55M
Deferred Revenue (Current)	62.21K	0	0	1000K	247.32K	22.34K	0	0	0	0
Other Current Liabilities	0	0	0	111.21K	165.27K	799.73K	1.3M	2.7M	3.47M	3.35M
Current Ratio	0.29x	0.54x	0.69x	0.82x	0.75x	1.19x	1.33x	2.58x	1.51x	0.99x
Quick Ratio	0.19x	0.45x	0.47x	0.68x	0.63x	1.09x	1.23x	2.42x	1.31x	0.82x
Cash Conversion Cycle	-43.2	35.33	29.42	19.91	39.37	110.34	127.18	109.03	95.45	56.96
Total Non-Current Liabilities+	0	0	0	1.74M	2.1M	13.72M	15.12M	6.63M	5.65M	4.02M
Long-Term Debt	0	0	0	1.55M	0	11.27M	12.72M	2.86M	3.04M	1.56M
Capital Lease Obligations	0	0	0	0	435.55K	778.71K	844.42K	860.1K	850.13K	501.8K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	183.58K	1.66M	1.66M	1.55M	2.91M	1.76M	1.96M
Total Liabilities	1.91M	4.87M	13.7M	24.01M	30.34M	48.01M	45.05M	28.38M	29.97M	29.78M
Total Debt+	474.14K	3.2M	10.18M	16.58M	19.29M	32.04M	27.12M	12.03M	12.42M	11.82M
Net Debt	276.09K	2.48M	9.4M	15.71M	19.25M	31.41M	26.84M	-8.72M	8.59M	11.51M
Debt / Equity	-	-	-	-	-	-	6.19x	0.30x	0.34x	0.48x
Debt / EBITDA	-	-	-	-	138.93x	10.30x	-	-	-	-
Net Debt / EBITDA	-	-	-	-	138.65x	10.10x	-	-	-	-
Interest Coverage	-4.90x	-0.98x	-2.98x	-0.18x	-0.15x	0.97x	-1.27x	-1.88x	-25.20x	-15.36x
Total Equity+	-1.25M	-1.75M	-3.03M	-3.32M	-6.46M	-4.16M	4.38M	39.66M	36.04M	24.53M
Equity Growth %	-1.23%	-0.4%	-0.73%	-0.1%	-0.95%	0.36%	2.05%	8.06%	-0.09%	-0.32%
Book Value per Share	-2.48	-3.49	-5.92	-6.23	-12.17	-7.82	6.67	20.57	3.01	1.28
Total Shareholders' Equity	-1.25M	-1.75M	-3.03M	-3.32M	-6.46M	-4.16M	4.38M	39.66M	36.04M	24.53M
Common Stock	125.63K	125.87K	12.82K	13.88K	13.22K	13.48K	702	10.61K	15.98K	23.69K
Retained Earnings	-401.22K	-1M	-7.21M	-16.27M	-19.57M	-18.75M	-34.35M	-66.23M	-91.64M	-114.02M
Treasury Stock	0	0	-95.88K	-225.49K	-411.85K	-611.85K	-816.71K	-816.71K	-917.16K	-917.16K
Accumulated OCI	-1.11M	-1.05M	-1.39M	32.83K	-16.34K	854.9K	-151.62K	-1.13M	-419.84K	-2.13M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-497.09K	-2.13M	-8.76M	-1.56M	-4.79M	-11.5M	-7.1M	-14.87M	-15.64M	-7.72M
Operating CF Margin %	-0.93%	-0.31%	-0.29%	-0.04%	-0.12%	-0.21%	-0.13%	-0.3%	-0.29%	-0.14%
Operating CF Growth %	-1.08%	-3.28%	-3.12%	0.82%	-2.08%	-1.4%	0.38%	-1.1%	-0.05%	0.51%
Net Income	-6.69M	-601K	-6.21M	-9.06M	-3.3M	820.79K	-7.96M	-13.83M	-18.54M	-16.18M
Depreciation & Amortization	5.42K	9.45K	25.9K	43.93K	394.63K	397.6K	449.69K	188.89K	614.38K	1.25M
Stock-Based Compensation	28.35K	16.64K	740.59K	242K	0	0	5.9M	24.4K	577.93K	1.69M
Deferred Taxes	0	0	0	0	0	-178.43K	-714.11K	780.1K	656.98K	-11.84K
Other Non-Cash Items	6.15M	16.06K	2.84M	6.55M	1.73M	-667.16K	1.52M	6.66M	8.96M	5.38M
Working Capital Changes	6.55K	-1.57M	-6.15M	667.35K	-3.61M	-11.87M	-6.3M	-8.69M	-7.9M	159.68K
Change in Receivables	-96.54K	-565.31K	-706.3K	465.45K	-4.32M	-15.72M	-8.46M	-7.46M	-4.03M	1.23M
Change in Inventory	-191.87K	-272.35K	-2.62M	1.43M	-271.45K	393.15K	-89.58K	-485.47K	-890.9K	146.45K
Change in Payables	193.68K	254.76K	809.12K	-629.72K	2.73M	3.21M	3.82M	1.73M	716.62K	1.05M
Cash from Investing+	-43.95K	-144.72K	-14.48K	-195.77K	588.93K	-117.74K	-826.82K	-21.5K	-13.76M	-798.27K
Capital Expenditures	-43.95K	-12.82K	-55.34K	-503.36K	-672.79K	-117.74K	-581.4K	-74.21K	-2.98M	-418.07K
CapEx % of Revenue	0.08%	0%	0%	0.01%	0.02%	0%	0.01%	0%	0.06%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-131.9K	0	0	0	0	-245.42K	55.34K	-5.55M	-380.19K
Cash from Financing+	329.12K	2.74M	9.29M	1.99M	3.59M	12.46M	7.27M	35.05M	12.69M	5.05M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	-6.2M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	24.14K	0	0	0	0	0	7.63M	2.82M	10.04M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-541.04K	-2.14M	-8.82M	-2.06M	-5.46M	-11.62M	-7.99M	-15.25M	-24.8M	-8.14M
FCF Margin %	-1.01%	-0.32%	-0.29%	-0.06%	-0.14%	-0.21%	-0.14%	-0.3%	-0.46%	-0.15%
FCF Growth %	-1.08%	-2.95%	-3.12%	0.77%	-1.65%	-1.13%	0.31%	-0.91%	-0.63%	0.67%
FCF per Share	-1.08	-4.26	-17.24	-3.87	-10.29	-21.83	-12.16	-7.91	-2.07	-0.42
FCF Conversion (FCF/Net Income)	0.07x	3.54x	1.41x	0.17x	1.45x	-14.01x	0.89x	1.08x	0.84x	0.48x
Interest Paid	0	0	0	0	447.73K	955.38K	2.06M	588.05K	406.88K	0
Taxes Paid	0	0	0	0	11.61K	14.13K	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-316.53%	-	-	-	-	-	-7289.22%	-62.81%	-48.99%	-53.43%
Return on Invested Capital (ROIC)	-14.56%	-20.82%	-102.97%	-9.82%	-1.52%	10.17%	-11.63%	-18.04%	-43.34%	-28.9%
Gross Margin	9.18%	8.9%	6.52%	6.5%	9.23%	14.55%	14.81%	11.83%	8.15%	7.92%
Net Margin	-1252.88%	-8.9%	-20.69%	-24.43%	-8.31%	1.48%	-14.16%	-27.47%	-34.74%	-29.73%
Debt / Equity	-	-	-	-	-	-	6.19x	0.30x	0.34x	0.48x
Interest Coverage	-4.90x	-0.98x	-2.98x	-0.18x	-0.15x	0.97x	-1.27x	-1.88x	-25.20x	-15.36x
FCF Conversion	0.07x	3.54x	1.41x	0.17x	1.45x	-14.01x	0.89x	1.08x	0.84x	0.48x
Revenue Growth	-93.01%	1165.53%	344.28%	23.56%	6.99%	39.65%	1.5%	-10.48%	6.02%	1.97%

Revenue by Segment

	2023	2024
Pharma manufacturing	344.71K	865.37K
Pharma manufacturing Growth	-	151.05%

Frequently Asked Questions

Growth & Financials

Cosmos Health Inc. (COSM) reported $59.8M in revenue for fiscal year 2024.

Cosmos Health Inc. (COSM) grew revenue by 2.0% over the past year. Growth has been modest.

Cosmos Health Inc. (COSM) reported a net loss of $18.5M for fiscal year 2024.

Dividend & Returns

Yes, Cosmos Health Inc. (COSM) pays a dividend with a yield of 59.69%. This makes it attractive for income-focused investors.

Cosmos Health Inc. (COSM) has a return on equity (ROE) of -53.4%. Negative ROE indicates the company is unprofitable.

Cosmos Health Inc. (COSM) had negative free cash flow of $10.3M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Cosmos Health Inc. (COSM) 10-Year Financial Performance & Capital Metrics

COSM • • Industrial / General

HealthcareSpecialty & Generic PharmaConsumer HealthcareOTC Medications

Revenue $54M +2.0%
EBITDA -$14M +32.6%
Net Income -$16M +12.7%
EPS (Diluted) -1.17 +45.6%
Gross Margin 7.92% -2.8%
EBITDA Margin -26.27% +33.9%
Operating Margin -28.56% +30.2%
Net Margin -29.73% +14.4%
ROE -53.43% -9.1%
ROIC -28.9% +33.3%
Debt/Equity 0.48 +39.8%
Interest Coverage -15.36 +39.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Trading at only 0.4x book value
✓Efficient asset utilization: 1.0x turnover

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Shares diluted 60.0% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y21.7%

5Y6.53%

3Y-1.09%

TTM6.69%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM9.07%

EPS CAGR

10Y-

5Y-

3Y-

TTM49.2%

ROCE

10Y Avg-19.93%

5Y Avg-8.65%

3Y Avg-38.87%

Latest-44.26%

Peer Comparison

OTC Medications

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HLNHaleon plc	43.51B	9.77	30.53	-0.61%	11.72%	16.31%	4.71%	0.62
UPCUniverse Pharmaceuticals Inc.	2.59M	4.59	-0.00	-28.74%	-37.94%	-31.64%		0.18
PRPHProPhase Labs, Inc.	711.94K	0.17	-0.07	-84.75%	-38.72%	-6.08%		3.34
COSMCosmos Health Inc.	20.24M	0.54	-0.46	1.97%	-31.01%	-80.15%		0.48
PRGOPerrigo Company plc	2.09B	15.17	-12.14	-6.06%	-1.21%	-1.17%	11.72%	0.84

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	533.8K	6.76M	30.01M	37.08M	39.68M	55.41M	56.24M	50.35M	53.38M	54.43M
Revenue Growth %	-0.93%	11.66%	3.44%	0.24%	0.07%	0.4%	0.02%	-0.1%	0.06%	0.02%
Cost of Goods Sold+	484.81K	6.15M	28.06M	34.68M	36.01M	47.35M	47.91M	44.39M	49.03M	50.12M
COGS % of Revenue	0.91%	0.91%	0.93%	0.94%	0.91%	0.85%	0.85%	0.88%	0.92%	0.92%
Gross Profit+	48.99K	601.04K	1.96M	2.41M	3.66M	8.06M	8.33M	5.96M	4.35M	4.31M
Gross Margin %	0.09%	0.09%	0.07%	0.06%	0.09%	0.15%	0.15%	0.12%	0.08%	0.08%
Gross Profit Growth %	-0.99%	11.27%	2.25%	0.23%	0.52%	1.2%	0.03%	-0.28%	-0.27%	-0.01%
Operating Expenses+	491.45K	803.55K	6.83M	3.64M	3.92M	5.35M	12.86M	13.43M	26.18M	19.86M
OpEx % of Revenue	0.92%	0.12%	0.23%	0.1%	0.1%	0.1%	0.23%	0.27%	0.49%	0.36%
Selling, General & Admin	486.04K	794.1K	4.85M	3.59M	3.52M	4.95M	12.41M	13.24M	25.57M	12.09M
SG&A % of Revenue	0.91%	0.12%	0.16%	0.1%	0.09%	0.09%	0.22%	0.26%	0.48%	0.22%
Research & Development	0	0	0	0	0	0	0	0	0	533.29K
R&D % of Revenue	-	-	-	-	-	-	-	-	-	0.01%
Other Operating Expenses	5.42K	9.45K	1.98M	43.93K	394.63K	397.6K	449.69K	188.89K	614.38K	7.23M
Operating Income+	-442.46K	-202.51K	-4.87M	-1.23M	-255.81K	2.71M	-4.53M	-7.47M	-21.83M	-15.54M
Operating Margin %	-0.83%	-0.03%	-0.16%	-0.03%	-0.01%	0.05%	-0.08%	-0.15%	-0.41%	-0.29%
Operating Income Growth %	-1.06%	0.54%	-23.06%	0.75%	0.79%	11.61%	-2.67%	-0.65%	-1.92%	0.29%
EBITDA+	-437.04K	-193.06K	-4.85M	-1.18M	138.82K	3.11M	-4.08M	-7.29M	-21.22M	-14.3M
EBITDA Margin %	-0.82%	-0.03%	-0.16%	-0.03%	0%	0.06%	-0.07%	-0.14%	-0.4%	-0.26%
EBITDA Growth %	-1.06%	0.56%	-24.1%	0.76%	1.12%	21.42%	-2.31%	-0.78%	-1.91%	0.33%
D&A (Non-Cash Add-back)	5.42K	9.45K	25.9K	43.93K	394.63K	397.6K	449.69K	188.89K	614.38K	1.25M
EBIT	-6.6M	-394.22K	-4.57M	-2.24M	-1.38M	3.99M	-4.27M	-9.09M	-17.68M	-15.17M
Net Interest Income+	-89.32K	-206.01K	-1.64M	-6.81M	-1.73M	-2.73M	-3.53M	-3.73M	-203.62K	-605.87K
Interest Income	1.06K	0	0	0	0	65.86K	46.32K	236.35K	662.86K	406.45K
Interest Expense	90.38K	206.01K	1.64M	6.81M	1.73M	2.8M	3.58M	3.97M	866.48K	1.01M
Other Income/Expense	-6.25M	-397.73K	-1.33M	-7.81M	-2.86M	-1.52M	-3.31M	-5.58M	3.29M	-638.19K
Pretax Income+	-6.69M	-600.23K	-6.21M	-9.04M	-3.12M	1.2M	-7.85M	-13.06M	-18.54M	-16.18M
Pretax Margin %	-12.53%	-0.09%	-0.21%	-0.24%	-0.08%	0.02%	-0.14%	-0.26%	-0.35%	-0.3%
Income Tax+	203	769	2.8K	17.33K	182.81K	377.54K	114.01K	775.05K	0	0
Effective Tax Rate %	1%	1%	1%	1%	1.06%	0.68%	1.01%	1.06%	1%	1%
Net Income+	-6.69M	-601K	-6.21M	-9.06M	-3.3M	820.79K	-7.96M	-13.83M	-18.54M	-16.18M
Net Margin %	-12.53%	-0.09%	-0.21%	-0.24%	-0.08%	0.01%	-0.14%	-0.27%	-0.35%	-0.3%
Net Income Growth %	-2.11%	0.91%	-9.33%	-0.46%	0.64%	1.25%	-10.7%	-0.74%	-0.34%	0.13%
Net Income (Continuing)	-6.69M	-601K	-6.21M	-9.06M	-3.3M	820.79K	-7.96M	-13.83M	-18.54M	-16.18M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-13.31	-1.20	-12.25	-17.02	-6.21	1.54	-23.74	-33.16	-2.15	-1.17
EPS Growth %	-2.06%	0.91%	-9.21%	-0.39%	0.64%	1.25%	-16.42%	-0.4%	0.94%	0.46%
EPS (Basic)	-13.31	-1.25	-12.25	-17.02	-6.21	1.55	-23.74	-33.16	-2.15	-1.17
Diluted Shares Outstanding	502.46K	502.59K	511.2K	532.26K	530.94K	532.31K	656.93K	1.93M	11.97M	19.15M
Basic Shares Outstanding	502.46K	480.8K	506.92K	532.26K	530.94K	530.8K	656.93K	1.93M	11.97M	19.15M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	547.18K	2.64M	9.51M	18.35M	21.18M	40.77M	39.83M	56.04M	36.61M	25.46M
Cash & Short-Term Investments	198.05K	716.59K	782.85K	3.58M	277.48K	851.19K	297.95K	20.76M	3.85M	336.25K
Cash Only	198.05K	716.59K	782.85K	864.34K	38.54K	628.39K	286.49K	20.75M	3.83M	315.11K
Short-Term Investments	0	0	0	2.72M	238.94K	222.79K	11.47K	14.88K	20.07K	21.15K
Accounts Receivable	96.54K	793.75K	1.43M	4.94M	9.27M	26.91M	30.14M	22.76M	21.71M	15.88M
Days Sales Outstanding	66.01	42.89	17.35	48.65	85.26	177.27	195.59	165.02	148.47	106.5
Inventory	191.87K	464.22K	3.09M	3.2M	3.47M	3.29M	3.15M	3.45M	4.79M	4.36M
Days Inventory Outstanding	144.46	27.53	40.24	33.71	35.21	25.38	23.98	28.38	35.65	31.72
Other Current Assets	0	0	772.62K	189.76K	665.49K	1.1M	-4.77K	9.07M	1.95M	4.89M
Total Non-Current Assets+	110.44K	481.92K	1.17M	2.35M	2.7M	3.07M	9.6M	11.67M	29.41M	28.85M
Property, Plant & Equipment	50.53K	52.72K	114.57K	1.43M	1.73M	1.76M	2.93M	2.93M	11.62M	10.4M
Fixed Asset Turnover	10.56x	128.15x	261.97x	26.01x	22.87x	31.53x	19.17x	17.18x	4.60x	5.23x
Goodwill	0	0	0	49.7K	49.7K	49.7K	49.7K	49.7K	49.7K	49.7K
Intangible Assets	0	0	41.99K	247.07K	213.98K	180.81K	436.07K	657.22K	7.63M	7.71M
Long-Term Investments	0	0	0	0	4.38K	0	0	0	165.93K	5.77M
Other Non-Current Assets	59.92K	429.2K	1.01M	624.48K	698.06K	905.32K	5.33M	8.03M	9.94M	4.92M
Total Assets+	657.62K	3.12M	10.68M	20.69M	23.88M	43.84M	49.43M	68.04M	66.01M	54.31M
Asset Turnover	0.81x	2.17x	2.81x	1.79x	1.66x	1.26x	1.14x	0.74x	0.81x	1.00x
Asset Growth %	-0.91%	3.74%	2.42%	0.94%	0.15%	0.84%	0.13%	0.38%	-0.03%	-0.18%
Total Current Liabilities+	1.91M	4.87M	13.7M	22.27M	28.24M	34.29M	29.93M	21.75M	24.32M	25.76M
Accounts Payable	336.93K	591.69K	2.17M	5.93M	8M	11.97M	12.13M	10.26M	11.91M	11.16M
Days Payables Outstanding	253.67	35.09	28.18	62.46	81.1	92.31	92.39	84.36	88.68	81.26
Short-Term Debt	474.14K	3.2M	10.18M	15.02M	18.65M	19.7M	13.34M	8.04M	8.23M	9.55M
Deferred Revenue (Current)	62.21K	0	0	1000K	247.32K	22.34K	0	0	0	0
Other Current Liabilities	0	0	0	111.21K	165.27K	799.73K	1.3M	2.7M	3.47M	3.35M
Current Ratio	0.29x	0.54x	0.69x	0.82x	0.75x	1.19x	1.33x	2.58x	1.51x	0.99x
Quick Ratio	0.19x	0.45x	0.47x	0.68x	0.63x	1.09x	1.23x	2.42x	1.31x	0.82x
Cash Conversion Cycle	-43.2	35.33	29.42	19.91	39.37	110.34	127.18	109.03	95.45	56.96
Total Non-Current Liabilities+	0	0	0	1.74M	2.1M	13.72M	15.12M	6.63M	5.65M	4.02M
Long-Term Debt	0	0	0	1.55M	0	11.27M	12.72M	2.86M	3.04M	1.56M
Capital Lease Obligations	0	0	0	0	435.55K	778.71K	844.42K	860.1K	850.13K	501.8K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	183.58K	1.66M	1.66M	1.55M	2.91M	1.76M	1.96M
Total Liabilities	1.91M	4.87M	13.7M	24.01M	30.34M	48.01M	45.05M	28.38M	29.97M	29.78M
Total Debt+	474.14K	3.2M	10.18M	16.58M	19.29M	32.04M	27.12M	12.03M	12.42M	11.82M
Net Debt	276.09K	2.48M	9.4M	15.71M	19.25M	31.41M	26.84M	-8.72M	8.59M	11.51M
Debt / Equity	-	-	-	-	-	-	6.19x	0.30x	0.34x	0.48x
Debt / EBITDA	-	-	-	-	138.93x	10.30x	-	-	-	-
Net Debt / EBITDA	-	-	-	-	138.65x	10.10x	-	-	-	-
Interest Coverage	-4.90x	-0.98x	-2.98x	-0.18x	-0.15x	0.97x	-1.27x	-1.88x	-25.20x	-15.36x
Total Equity+	-1.25M	-1.75M	-3.03M	-3.32M	-6.46M	-4.16M	4.38M	39.66M	36.04M	24.53M
Equity Growth %	-1.23%	-0.4%	-0.73%	-0.1%	-0.95%	0.36%	2.05%	8.06%	-0.09%	-0.32%
Book Value per Share	-2.48	-3.49	-5.92	-6.23	-12.17	-7.82	6.67	20.57	3.01	1.28
Total Shareholders' Equity	-1.25M	-1.75M	-3.03M	-3.32M	-6.46M	-4.16M	4.38M	39.66M	36.04M	24.53M
Common Stock	125.63K	125.87K	12.82K	13.88K	13.22K	13.48K	702	10.61K	15.98K	23.69K
Retained Earnings	-401.22K	-1M	-7.21M	-16.27M	-19.57M	-18.75M	-34.35M	-66.23M	-91.64M	-114.02M
Treasury Stock	0	0	-95.88K	-225.49K	-411.85K	-611.85K	-816.71K	-816.71K	-917.16K	-917.16K
Accumulated OCI	-1.11M	-1.05M	-1.39M	32.83K	-16.34K	854.9K	-151.62K	-1.13M	-419.84K	-2.13M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-497.09K	-2.13M	-8.76M	-1.56M	-4.79M	-11.5M	-7.1M	-14.87M	-15.64M	-7.72M
Operating CF Margin %	-0.93%	-0.31%	-0.29%	-0.04%	-0.12%	-0.21%	-0.13%	-0.3%	-0.29%	-0.14%
Operating CF Growth %	-1.08%	-3.28%	-3.12%	0.82%	-2.08%	-1.4%	0.38%	-1.1%	-0.05%	0.51%
Net Income	-6.69M	-601K	-6.21M	-9.06M	-3.3M	820.79K	-7.96M	-13.83M	-18.54M	-16.18M
Depreciation & Amortization	5.42K	9.45K	25.9K	43.93K	394.63K	397.6K	449.69K	188.89K	614.38K	1.25M
Stock-Based Compensation	28.35K	16.64K	740.59K	242K	0	0	5.9M	24.4K	577.93K	1.69M
Deferred Taxes	0	0	0	0	0	-178.43K	-714.11K	780.1K	656.98K	-11.84K
Other Non-Cash Items	6.15M	16.06K	2.84M	6.55M	1.73M	-667.16K	1.52M	6.66M	8.96M	5.38M
Working Capital Changes	6.55K	-1.57M	-6.15M	667.35K	-3.61M	-11.87M	-6.3M	-8.69M	-7.9M	159.68K
Change in Receivables	-96.54K	-565.31K	-706.3K	465.45K	-4.32M	-15.72M	-8.46M	-7.46M	-4.03M	1.23M
Change in Inventory	-191.87K	-272.35K	-2.62M	1.43M	-271.45K	393.15K	-89.58K	-485.47K	-890.9K	146.45K
Change in Payables	193.68K	254.76K	809.12K	-629.72K	2.73M	3.21M	3.82M	1.73M	716.62K	1.05M
Cash from Investing+	-43.95K	-144.72K	-14.48K	-195.77K	588.93K	-117.74K	-826.82K	-21.5K	-13.76M	-798.27K
Capital Expenditures	-43.95K	-12.82K	-55.34K	-503.36K	-672.79K	-117.74K	-581.4K	-74.21K	-2.98M	-418.07K
CapEx % of Revenue	0.08%	0%	0%	0.01%	0.02%	0%	0.01%	0%	0.06%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-131.9K	0	0	0	0	-245.42K	55.34K	-5.55M	-380.19K
Cash from Financing+	329.12K	2.74M	9.29M	1.99M	3.59M	12.46M	7.27M	35.05M	12.69M	5.05M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	-6.2M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	24.14K	0	0	0	0	0	7.63M	2.82M	10.04M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-541.04K	-2.14M	-8.82M	-2.06M	-5.46M	-11.62M	-7.99M	-15.25M	-24.8M	-8.14M
FCF Margin %	-1.01%	-0.32%	-0.29%	-0.06%	-0.14%	-0.21%	-0.14%	-0.3%	-0.46%	-0.15%
FCF Growth %	-1.08%	-2.95%	-3.12%	0.77%	-1.65%	-1.13%	0.31%	-0.91%	-0.63%	0.67%
FCF per Share	-1.08	-4.26	-17.24	-3.87	-10.29	-21.83	-12.16	-7.91	-2.07	-0.42
FCF Conversion (FCF/Net Income)	0.07x	3.54x	1.41x	0.17x	1.45x	-14.01x	0.89x	1.08x	0.84x	0.48x
Interest Paid	0	0	0	0	447.73K	955.38K	2.06M	588.05K	406.88K	0
Taxes Paid	0	0	0	0	11.61K	14.13K	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-316.53%	-	-	-	-	-	-7289.22%	-62.81%	-48.99%	-53.43%
Return on Invested Capital (ROIC)	-14.56%	-20.82%	-102.97%	-9.82%	-1.52%	10.17%	-11.63%	-18.04%	-43.34%	-28.9%
Gross Margin	9.18%	8.9%	6.52%	6.5%	9.23%	14.55%	14.81%	11.83%	8.15%	7.92%
Net Margin	-1252.88%	-8.9%	-20.69%	-24.43%	-8.31%	1.48%	-14.16%	-27.47%	-34.74%	-29.73%
Debt / Equity	-	-	-	-	-	-	6.19x	0.30x	0.34x	0.48x
Interest Coverage	-4.90x	-0.98x	-2.98x	-0.18x	-0.15x	0.97x	-1.27x	-1.88x	-25.20x	-15.36x
FCF Conversion	0.07x	3.54x	1.41x	0.17x	1.45x	-14.01x	0.89x	1.08x	0.84x	0.48x
Revenue Growth	-93.01%	1165.53%	344.28%	23.56%	6.99%	39.65%	1.5%	-10.48%	6.02%	1.97%

Revenue by Segment

	2023	2024
Pharma manufacturing	344.71K	865.37K
Pharma manufacturing Growth	-	151.05%

Frequently Asked Questions

Growth & Financials

Cosmos Health Inc. (COSM) reported $59.8M in revenue for fiscal year 2024.

Cosmos Health Inc. (COSM) grew revenue by 2.0% over the past year. Growth has been modest.

Cosmos Health Inc. (COSM) reported a net loss of $18.5M for fiscal year 2024.

Dividend & Returns

Yes, Cosmos Health Inc. (COSM) pays a dividend with a yield of 59.69%. This makes it attractive for income-focused investors.

Cosmos Health Inc. (COSM) has a return on equity (ROE) of -53.4%. Negative ROE indicates the company is unprofitable.

Cosmos Health Inc. (COSM) had negative free cash flow of $10.3M in fiscal year 2024, likely due to heavy capital investments.